Treatment with docetaxel and cisplatin in advanced adrenocortical carcinoma, a phase II study

BACKGROUND: Adrenocortical carcinoma (ACC) is a rare disease with a poor response to chemotherapy. Cisplatin is the most widely investigated drug in the treatment of ACC and in vitro studies have indicated activity of taxanes. The objectives of this study were to evaluate the efficacy and toxicity o...

Descripción completa

Detalles Bibliográficos
Autores principales: Urup, T, Pawlak, W Z, Petersen, P M, Pappot, H, Rørth, M, Daugaard, G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670472/
https://www.ncbi.nlm.nih.gov/pubmed/23652308
http://dx.doi.org/10.1038/bjc.2013.229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670472/
https://www.ncbi.nlm.nih.gov/pubmed/23652308
http://dx.doi.org/10.1038/bjc.2013.229

Ejemplares similares